Publications
Sunitinib in metastatic renal cell carcimoma: a single-center experience
V M Krishna 1 , V Noronha, K Prabhash, A Joshi, V Patil, B Bhosale, T Ravi, H Menon, S Gupta, S D Banavali, G Bakshi, H B Tangaonkar Abstract
Introduction: Historically, metastatic renal cell carcinoma (RCC) has had poor prognosis; the outcomes have improved with the introduction of tyrosine-kinase inhibitors, such as sunitinib. There is no reported literature from India on the use of sunitinib in metastatic RCC. We present an analysis of sunitinib at our institute over 4 years.
